21 results
C. Difficile Infection in IBD - IBD Algorithm

Background
Complications
CDI Testing Algorithm
CDI Recurrence

Dr. Wade Billings @wabillin

#Clostridioides #difficile #CDiff
Difficile Infection in IBD ... - IBD Algorithm ... Clostridioides #difficile #CDiff ... #CDifficile #IBD ... #Algorithm #Management
Clostridium Difficile Diagnosis and Management Algorithm

IDAGRAM based on most recent guidelines from @IDSAInfo.

 Infographic by IDagram
@ID_agram

#Clostridium
and Management Algorithm ... Clostridium #Difficile #Algorithm ... Diagnosis #Management #IDSA ... #CDiff
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
C.diff - Clostridioides ... immunocompromised, IBD ... Tx Management (IDSA ... /severe CDI IDSA ... ciab549 #CDI #Cdiff
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... Pearls: • IDA ... differentiate IDA ... modifications Algorithm ... #Algorithm #diagnosis
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm
Loss of Response:
 • (Re)consult Colorectal Surgery
 • Assess
Colitis - Management Algorithm ... Diff. & CMV COVID ... PJP Prophylaxis Algorithm ... UC #Management #Algorithm ... #IBD #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... itraconazolea 200 mg PO BID ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Fidaxomicin - 200 mg PO bid ... 50 mg IV every bid ... × 10 days #CDiff ... treatment #management #pharmacology ... #idsa #table
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... mg) PO (or IV) BID ... 160 mg/800 mg) BID ... IsosporaBelli #IDSA ... infections #HIVAIDS #pharmacology